Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • XRG to provide virtual reality training systems to boost frontline safety for police
    • News

    XRG to provide virtual reality training systems to boost frontline safety for police

    Virtual reality is changing how the world works. Previously, you would need to put yourself in physical jeopardy if you wanted to skydive, play tennis or break dance. Now, you can do all of it with a headset in your home. The concept is not just attractive to laymen but also to policemen, especially those

    Read More
    Public
  • Investing basics: Why you should consider ETFs
    • Explainers

    Investing basics: Why you should consider ETFs

    If you are keen on passive investing but not keen on making risky investments (aka stock picking in the current environment of heightened volatility), then ETF stocks might be the perfect and safer vehicle to kickstart your passive investment journey. That’s because ETFs allow investors to buy large groups of shares through a single investment.

    Read More
    Public
  • Shriro to close its kitchen appliances business in Australia amid rising competition
    • News

    Shriro to close its kitchen appliances business in Australia amid rising competition

    When the going gets tough, some decide that it’s too much to get going and take a backseat instead. That’s the case of the kitchen appliances and consumer products company Shriro Holdings (ASX: SHM), which has decided to shut its kitchen appliances business in the Australian market in light of growing competition, rising inflation and

    Read More
    Public
  • Sigma makes its way back to profitability after a few lean years
    • News

    Sigma makes its way back to profitability after a few lean years

    Bought a rapid antigen test (RAT) lately? Odds are, you haven’t even thought about it. Even as the weather changes prompt illnesses, Covid is not a top concern for many people anymore, resulting in a fall in demand for RATs and Covid-related medicines. Plus, over the past year, labour shortages have been the bane of

    Read More
    Public
  • German researchers publish ‘best ever’ results for urgently needed blood cancer treatment
    • News

    German researchers publish ‘best ever’ results for urgently needed blood cancer treatment

    There is an urgent need for better treatment for myelodysplastic syndrome (MDS), a type of blood cancer, and new research published in prestigious scientific journal Nature Communications suggests a breakthrough could be coming. Researchers at the University of Heidelberg in Germany have reported results claimed to be “the best we have ever observed in our

    Read More
    Public
  • Clee Capital takes legal action against IOUPay with help of director accused of fraud
    • News

    Clee Capital takes legal action against IOUPay with help of director accused of fraud

    Fraud, losses, oustings and backtracking on deals—you’d think digital payments firm IOUPay (ASX: IOU)’s coffin couldn’t take any more nails. Untrue. The Company is now facing a new woe—and a big one at that: legal action via a disgruntled former CFO. IOUPay is being sued by one of its shareholders, Clee Capital, which holds 5.08%

    Read More
    Public
  • «
  • ‹
  • 266
  • 267
  • 268
  • 269
  • 270
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.